Atlas Trials

Trial to Investigate the Effect of Dapagliflozin on Ischemia Reperfusion Induced Endothelial Dysfunction

Clinical trial NCT05217654 · UNKNOWN

Trial details

NCT number
NCT05217654
Sponsor
Medical University of Vienna
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Reperfusion InjuryVascular Complications
Start date
2022-02-18
Primary completion
2023-02-01
Enrollment
32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.